Stock Screener App

Frei -

Installieren

61.87

2.65% 1.60

Royalty Pharma Plc (RPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.91% 674.14	630.58	621.99	609.29	578.66
Research and Development	145.92% 97.85	39.79	-	-	-
Costs And Expenses	701.06% 541.02	67.54	233.61	182.13	368.87
Operating Income/Loss	76.36% 133.12	563.04	388.38	427.16	209.80
Nonoperating Income/Loss	45.52% -51.63	-94.78	-32.47	17.05	-119.16
Income/Loss From Equity Method Investments	81.26% 4.077	21.76	4.005	15.95	2.693
Income/Loss From Continuing Operations Before Tax	82.60% 81.49	468.26	355.91	444.21	90.64
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	82.60% 81.49	468.26	355.91	444.21	90.64
Attributable To Noncontrolling Interest	63.36% 63.60	173.57	141.71	155.99	60.46
Basic Average Shares	1.89% 445.06	436.79	-0.48	431.89	423.51
Diluted Average Shares	0.01% 556.90	556.84	-2.299	559.61	562.30
Basic Earnings Per Share	94.03% 0.04	0.67	0.50	0.67	0.07
Diluted Earnings Per Share	94.03% 0.04	0.67	0.50	0.67	0.07
Common Stock Dividends	0.00% 0.235	0.235	0.22	0.22	0.22

ROIV

$35.07

1.07%

GMAB

$39.23

1.88%

ALNY

$231.78

0.65%

INCY

$116.10

2.52%

BNTX

$89.97

0.85%

INSM

$95.51

0.23%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters